SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-002005
Filing Date
2024-02-28
Accepted
2024-02-28 16:16:09
Documents
98
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K knsa-20231231x10k.htm   iXBRL 10-K 3531249
2 EX-10.36 knsa-20231231xex10d36.htm EX-10.36 90024
3 EX-19.1 knsa-20231231xex19d1.htm EX-19.1 162858
4 EX-23.1 knsa-20231231xex23d1.htm EX-23.1 2211
5 EX-31.1 knsa-20231231xex31d1.htm EX-31.1 14218
6 EX-31.2 knsa-20231231xex31d2.htm EX-31.2 14161
7 EX-32.1 knsa-20231231xex32d1.htm EX-32.1 7694
8 EX-32.2 knsa-20231231xex32d2.htm EX-32.2 7608
9 EX-97.1 knsa-20231231xex97d1.htm EX-97.1 62900
10 GRAPHIC knsa-20231231x10k006.jpg GRAPHIC 77613
11 GRAPHIC knsa-20231231xex19d1001.jpg GRAPHIC 9830
12 GRAPHIC knsa-20231231xex97d1001.jpg GRAPHIC 9830
  Complete submission text file 0001558370-24-002005.txt   13371129

Data Files

Seq Description Document Type Size
13 EX-101.SCH knsa-20231231.xsd EX-101.SCH 74587
14 EX-101.CAL knsa-20231231_cal.xml EX-101.CAL 73612
15 EX-101.DEF knsa-20231231_def.xml EX-101.DEF 322459
16 EX-101.LAB knsa-20231231_lab.xml EX-101.LAB 666956
17 EX-101.PRE knsa-20231231_pre.xml EX-101.PRE 508684
100 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20231231x10k_htm.xml XML 2369487
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38492 | Film No.: 24695603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)